AWA Point
EORI number mandatory to file actions against counterfeit goods in the EU
By Mette Parlev | Posted on November 25, 2020
Danish customs oversee thousands of counterfeit goods each year and over the past five years, the number of cases of counterfeit goods has quadrupled. This has also caused the number of intervention cases to increase. Rights holders have a very short time to react and file an intervention action when Danish customs find potential cases...
Filed under: Insights
Tags: counterfeits, Customs, EORI, EU
An Introduction to IP
By AWA | Posted on November 24, 2020
The first of a series of webinars gives you a short introduction to the different areas in IP. Hear about patents, trademarks, design protection and domain names. Rasmus Kvist Lund what the different areas within IP can be used for when you wish to protect your invention. This webinar is in Danish.
Filed under: Webinars
Bad news for WhatsApp as Norwegian Board of Appeal refuses to register logo
By AWA | Posted on November 23, 2020
With a reported total of more than 500 million users globally, many of us will have used or at least heard of WhatsApp. In a recent decision dated 24 September 2020, the Board of Appeal for Industrial Property Rights ruled against WhatsApp in its appeal against an earlier decision of the Norwegian Industrial Property Office...
The Busines of IP – Understanding and Creating Value: Part 1 – Venture Capital
By Anders Isaksson | Posted on November 18, 2020
In this six-part series, Anders Isaksson explores some of the key factors and motivators for why companies small or large should obtain intellectual property. The aim is to help you understand when and how you can create value from IP, especially when considering the long and short-term goals of a company. Whether you are a...
Filed under: Insights
Tags: due dilligence, Intellectual Property, investors, IP, venture capital
Protecting Biological Drug Innovations
By AWA | Posted on November 11, 2020
Learn how to protect biological drug innovations during this webinar from Stockholm Science City (In Swedish). Ulrika Munter and Nora Spjuth share their experiences working with intellectual property in this field and Linus Plym Forshell from the Swedish Intellectual Property Office (PRV) provides an overview of IP strategies in the pharmaceutical sector. This webinar is in Swedish.
Tags: biological, drugs, innovations, patents, PRV
How the amended Norwegian Trade Marks Act will affect applicants and owners
By AWA | Posted on October 30, 2020
The upcoming amendments to the Norwegian Trade Marks Act align law and practice with the EEA, but also provides opportunities for trademark owners and applicants in terms of enhanced registration and protection scope as well as considerations for alternate filing strategies The European Economic Area (EEA) Joint Committee decided on February 7, 2020, to implement...
Filed under: Insights
Tags: EEA, NIPO, Norway, Trademark Directive (EU 2015/2436), trademarks
China issues Opinions on destroying infringing and counterfeit goods
By Ai-Leen Lim | Posted on October 15, 2020
On August 13, 2020, nine of China’s authorities including the Supreme People’s Court and the State Administration for Market Regulation jointly released the Opinions on Strengthening the Destruction of Infringing and Counterfeit Goods (Opinions). The nine authorities involved are: National Leading Group for Combating Infringement and Counterfeiting, Publicity Department of the Communist Party of China,...
Filed under: Insights
Tags: china, counterfeit, destruction, Infringement, trademarks
CNIPA publishes trademark infringement criteria
By Ai-Leen Lim | Posted on October 15, 2020
To help strengthen and guide trademark law enforcement, provide uniform criteria for law enforcement, strengthen the protection of exclusive rights to use trademarks and create a good business environment, the China National Intellectual Property Administration (CNIPA) has enacted the Criteria for Judging Trademark Infringement (Criteria), which went into effect on June 15, 2020. The Criteria...
Nobel prize awarded to Crispr-patent tussle party Charpentier and Doudna
By Joanna Applequist | Posted on October 7, 2020
The Nobel committee has announced that this year’s prize in Chemistry is awarded to Doudna and Charpentier for their groundbreaking research leading to the development of the Crispr-Cas 9 technology, often referred to as the gene scissors. The Crispr-Cas 9 technology was first published as a scientific paper in 2012 by Doudna and Charpentier. This...
Filed under: Insights
Tags: Broad Institute, Crispr-Cas 9, Nobel, Patent, UC Berkley
EU requires manufacturers to disclose scientific documents during risk assessment for food chain production
By Eric Van Malderen | Posted on September 30, 2020
The European Food Safety Agency (EFSA) is in charge of the registration into the European Union of novel foods and feeds, food and feed additives, food and feed contact materials, GMO’s, plant protection products, food and feed enzymes as well as food and feed flavourings. To increase the legitimacy and credibility of their opinions, food...
Filed under: Insights
Tags: EFSA, EU, European Union, Food, Manufacturing, patents, trade secrets
Recent contributors
Partner, Attorney at Law, Business Area Manager
Associate, Attorney at Law, European Trademark and Design Attorney
Senior Associate, Patents
Partner, European Patent Attorney, Authorised Swedish Patent Attorney, UPC Representative
Partner, Attorney at Law, Group Vice President
Senior Associate, Attorney at Law